100% Quality Guarantee
PhD-Level Technical Support
Anti-CD20 rituximab biosimilar mAb HDBS0025
Key Features

Rituximab Biosimilar (CD20) Antibody (HDBS0025)

SKU HDBS0025
Antibody Type Biosimilar Reference Antibody
Applications Drug Development
Applications Inflammatory Response Assays
Applications Pharmacokinetics
Disease Area B-Cell Lymphomas
Disease Area Autoimmune Diseases
Protein CD20
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Rituximab Biosimilar (CD20) Antibody (HDBS0025)

The CD20 Rituximab Biosimilar Monoclonal Antibody (HDBS0025) is a cutting-edge tool for researchers studying CD20, a cell surface protein involved in immune response regulation. This biosimilar monoclonal antibody, derived from rituximab, has been carefully developed to target and bind specifically to the CD20 protein, allowing for precise detection and analysis in a variety of cell types.CD20 is known for its critical role in B cell function and is a common target for therapies in diseases such as leukemia, lymphoma, and autoimmune disorders. The CD20 Rituximab Biosimilar Monoclonal Antibody offers researchers a reliable tool for studying the expression and function of CD20, providing valuable insights into the mechanisms underlying these diseases.

With its high specificity and reactivity with human samples, this antibody is ideal for use in various research applications, including Western blot and immunohistochemistry. By enabling detailed investigation of CD20 biology, the Anti-CD20 Rituximab Biosimilar Monoclonal Antibody holds great promise for advancing our understanding of immune-related diseases and developing innovative therapeutic strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose